Results 201 to 210 of about 6,770,863 (365)

PREVALANCE AND ASSOCIATED RISK FACTORS FOR SYPHILIS IN WOMENS WITH RECURRENTS MISCARRIAGE

, 1969
Arshad Hussain Laghari, Viqar Sultana, Akhtar Hussain Samoo, Pirbhomal Makhija, Jehan Ara, Hira   +5 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Treatment planning with a 2.5 MV photon beam for radiation therapy

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose The shallow depth of maximum dose and higher dose fall‐off gradient of a 2.5 MV beam along the central axis that is available for imaging on linear accelerators is investigated for treatment of shallow tumors and sparing the organs at risk (OARs) beyond it.
Navid Khaledi, Chris Hayes, Louise Belshaw, Mark Grattan, Rao Khan, James L. Gräfe   +5 more
wiley   +1 more source

AGE AND GENDER WISE DISTRIBUTIONOF RISK FACTORS AMONG PATIENTS WITHCORONORY ARTERY DISEASE.

, 1969
Muhammad Iqbal, Ikramullah Ikramullah, Abdul Hadi, Farooq Ahmad, Muhammad Rehanul Haq, Muhammad Adil, Muhammad Nauman, Muhammad Hafizullah   +7 more
openalex   +2 more sources

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Volume staging for arteriovenous malformation SRS treatment using VMAT

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Volume staging involves dividing the target volume into smaller parts and treating each part separately. In this study, the feasibility of volume‐staged stereotactic radiosurgery (VS‐SRS) on a linear accelerator using volumetric modulated arc therapy (VMAT) and a frameless patient positioning system is investigated.
Claudia Mendez, Ermias Gete
wiley   +1 more source

Flecainide and elevated liver enzymes in α1-antitrypsin deficiency

HeartRhythm Case Reports, 2016
David J.A. Jenkins, MD, PhD, FRCP, Michael Freeman, MD, FRCPC, Iqwal Mangat, MD, FRCPC, Koruba Srichaikul, MD, MSc, Viranda H. Jayalath, MSc, Dorothea Faulkner, RD, PhD, John L. Sievenpiper, MD, PhD, FRCPC, Cyril W.C. Kendall, PhD, Alexander Romaschin, PhD, Young-In Kim, MD, FRCPC, Paul Dorian, MD, FRCPC, FHRS   +10 more
doaj   +1 more source

Is air pollution a risk factor for early menopause? [PDF]

BMC Public Health
Kim JM, Shah S, Min J, Jeong K, Ha EH.
europepmc   +1 more source

Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia

, 1970
Shewaneh Damtie, Belete Biadgo, Habtamu Wondifraw Baynes, Sintayehu Ambachew, Tadele Melak, Daniel Asmelash, Molla Abebe   +6 more
openalex   +1 more source

Plasma lipids in a London population and their relation to other risk factors for coronary heart disease. [PDF]

, 1978
J. H. Fuller, S.L Pinney, R. J. Jarrett, Kent J. Kilbourn, H. Keen   +4 more
openalex   +1 more source